Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Aquilion ONE (TSX-305A/3) V8.3 with FIRST 2.1

K-Number: K170177 · 2017-06-30

Decision Date2017-06-30
Product CodeJAK
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Aquilion ONE (TSX-305A/3) V8.3 with FIRST 2.1 is a medical device manufactured by Toshibamedical Systems Corporation. It received FDA 510(k) clearance on 2017-06-30 under approval number K170177. The device is classified under product code JAK. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Aquilion ONE (TSX-305A/3) V8.3 with FIRST 2.1?

Aquilion ONE (TSX-305A/3) V8.3 with FIRST 2.1 is a medical device that received FDA 510(k) clearance on 2017-06-30. It is manufactured by Toshibamedical Systems Corporation. The 510(k) number is K170177.

When was Aquilion ONE (TSX-305A/3) V8.3 with FIRST 2.1 approved by the FDA?

Aquilion ONE (TSX-305A/3) V8.3 with FIRST 2.1 received FDA 510(k) clearance on 2017-06-30, under approval number K170177.

What company makes Aquilion ONE (TSX-305A/3) V8.3 with FIRST 2.1?

Aquilion ONE (TSX-305A/3) V8.3 with FIRST 2.1 is manufactured by Toshibamedical Systems Corporation.

What is the FDA product code for Aquilion ONE (TSX-305A/3) V8.3 with FIRST 2.1?

The FDA product code for Aquilion ONE (TSX-305A/3) V8.3 with FIRST 2.1 is JAK.

Other Devices by Toshibamedical Systems Corporation

View all 27 devices →

Related Devices (Code: JAK)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.